Translational inefficiency of acid β-glucosidase mRNA in transgenic mammalian cells

Molecular Genetics and Metabolism

Volumn 64, Issue 2, 1998, Pages 87-98

  Xu, You Hai ^a   Grabowski, Gregory A ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; COMPLEMENTARY DNA; GLUCOSYLCERAMIDASE; MESSENGER RNA; PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVITY; GAUCHER DISEASE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LEPIDOPTERA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSLATION; SKIN FIBROBLAST; TRANSGENE;

ANIMALIA; INSECTA; LEPIDOPTERA; MAMMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0031717113     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1998.2709     Document Type: Article

References (52)

1. Adam S A, Nakagawa T, Swanson M S, Woodruff T K, Dreyfuss G. mRNA polyadenylate-binding protein: Gene isolation and sequencing and identification of a ribonucleoprotein consensus sequence. Mol Cell Biol. 6:1986;2932-2943.
2. Anderson W F. Human gene therapy. Science. 256:1992;808-813.
3. Ashley C T Jr, Wilkinson K D, Reines D, Warren S T. FMR1 protein: Conserved RNP family domains and selective RNA binding. Science. 262:1993;563-566.
4. Ausubel F M, Brent R, Kingston R E, Moore D D, Seidman J G, Smith J A, Struhl K. Current Protocols in Molecular Biology. 1992;Greene Pub and Wiley-Interscience. p. 12.1-12.9.
5. Bag J, Sarkar S. Cytoplasmic nonpolysomal messenger RNA in chicken embryotic muscles. Biochemistry. 14:1975;3800-3807.
6. Bansal V, Mowery-Rushton P, Lucht L, Li J, Bahnson A, Watkins S C, Barranger J A. Transduction, expression, and secretion of human glucocerebrosidase by murine myoblasts. Ann NY Acad Sci. 716:1994;307-320.
7. Barton N W, Brady R O, Dambrosia J M, Di Bisceglie A M, Doppelt S H, Hill S C, Mankin H J, Murray G J, Parker R I, Argoff C E. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. N Engl J Med. 324:1991;1464-1470.
8. Beutler, E, Grabowski, G, A, Glucosylceramide lipidoses: Gaucher disease. The metabolic and molecular basis of inherited disease, The Metabolic Basis of Inherited Disease, New York, McGraw Hill, 1995, 2641, 2670.
9. Bodine D M, McDonagh K T, Brandt S J, Ney P A, Agricola B, Byrne E, Nienhuis A W. Development of a high-titre retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells. Proc Natl Acad Sci USA. 87:1990;3738-3742.
10. Cao J, Geballe A P. Coding sequence-dependent ribosomal arrest at termination of translation. Mol Cell Biol. 16:1996;603-608.
11. Choudary P V, Barranger J A, Tsuji S, Mayor J, LaMarca M E, Cepko C L, Mulligan R C, Ginns E I. Retrovirus-mediated transfer of the human glucocerebrosidase gene to Gaucher fibroblasts. Mol Biol Med. 3:1986;293-299.
12. Correl P H, Colilla S, Dave H PG, Karlsson S. High levels of human glucocerebrosidase activity in macrophages of long-term reconstituted mice after retroviral infection of hematopoietic stem cells. Blood. 80:1992;331-336.
13. Correll P H, Fink J K, Brady R O, Perry L K, Karlsson S. Production of human glucocerebrosidase in mice after retroviral gene transfer into multipotential hematopoietic progenitor cells. Proc Natl Acad Sci USA. 86:1989;8912-8916.
14. rd, New York, Academic Press, 1986, 69, 123.
15. Doll R F, Bruce A, Smith F I. Regulation of the human acid β-glucosidase promoter in multiple cell types. Biochim Biophys Acta. 1261:1995;57-67.
16. Fabbro D, Desnick R J, Grabowski G A. Gaucher disease: genetic heterogeneity within and among the subtypes detected by immunoblotting. Am J Hum Genet. 40:1987;15-31.
17. Gaetani S, Smith J A, Feldman R A, Morimoto T. Preparation of rough microsomes and membrane-bound polysomes that are active in protein synthesis in vitro. Meth Enzymol. 96:1983;3-24.
18. Gavrieli-Rorman E, Grabowski G A. Molecular cloning of a human co-β-glucosidase cDNA: Evidence that four sphingolipid hydrolase activator proteins are encoded by single genes in humans and rats. Genomics. 5:1989;486-492.
19. Grabowski G A, Barton N W, Pastores G, Banerjee T K, McKee A, Parker C, Schiffmann R, Dambrosia J M, Hill S C, Brady R O. Enzyme therapy in Gaucher disease type 1: Comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources. Ann Intern Med. 122:1995;33-39.
20. Grabowski G A, Saal H, Wenstrup R J. Gaucher disease: a prototype for molecular medicine. Crit Rev Hem Onco. 23:1996;25-55.
21. Grace M E, Berg A, He G-S, Goldberg L, Horowitz M, Grabowski G A. Gaucher disease: Heterologous expression of two alleles associated with neuronopathic phenotypes. Am J Hum Genet. 49:1991;646-655.
22. Graves P N, Grabowski G A, Ludman M D, Palese P, Smith F I. Human acid β-glucosidase: Northern blot and S1 nuclease analysis of mRNA from HeLa cells and normal and Gaucher disease fibroblasts. Am J Hum Genet. 39:1986;763-774.
23. Horowitz M, Wilder S, Horowitz Z, Reiner O, Gelbart T, Beutler E. The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics. 4:1989;87-96.
24. Imai K. Characterization of β-glucosidase as a peripheral enzyme of lysosomal membranes from mouse liver and purification. J Biochem (Tokyo). 98:1985;1405-1416.
25. Kozak M. At structural features in eukaryotic mRNA that modulate the initiation of translation. J Biol Chem. 266:1991;19,867-19,870.
26. Kozak M. The scanning model for translation: an update. J Cell Biol. 108:1989;229-241.
27. Krall W J, Skelton D C, Yu X J, Riviere I, Lehn P, Mulligan R C, Kohn D B. Increased level of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells. Gene Ther. 3:1996;37-48.
28. Kruh J, Borsook H. Hemoglobin synthesis in rabbit reticulocytes in vitro. J Biol Chem. 220:1956;905-915.
29. Latham T, Grabowski G A, Theophilus B D, Smith F I. Complex alleles of the acid β-glucosidase gene in Gaucher disease. Am J Hum Genet. 47:1990;79-86.
30. Leonova T, Qi X, Bencosme A, Ponce E, Sun Y, Grabowski G A. Proteolytic processing patterns of prosaposin in insect and mammalian cells. J Biol Chem. 271:1996;17312-17320.
31. Lynch C M, Miller A D. Production of high-titre helper virus-free retroviral vectors by cocultivation of packaging cells with different host ranges. J Virol. 65:1991;3887-3890.
32. Markowitz D M, Goff S, Bank A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology. 167:1988;400-406.
33. Mathews M B, Sonenberg N, Hershey J WB. Origins and target of translational control. Hershey J WB, Mathews M B, Sonenberg N. Translational Control. 1996;1-29 Cold Spring Harbor Laboratory Press.
34. Meyuhas O, Thompson E A, Perry R P. Glucocorticoids selectively inhibit translation of ribosomal protein mRNA in lymphosarcoma cells. Mol Cell Biol. 7:1987;2691-2699.
35. Miller A D. Human gene therapy comes of age. Nature. 357:1992;455-460.
36. Nolta J A, Yu X J, Bahner I, Kohn D B. Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow. J Clin Invest. 90:1992;342-348.
37. Nolta J A, Sender L S, Barranger J A, Kohn D B. Expression of human glucocerebrosidase in murine long-term bone marrow cultures after retroviral vector-mediated transfer. Blood. 75:1990;787-797.
38. Ohashi T, Boggs S, Robbins P, Bahnson A, Patrene K, Wei F, Wei J, Li J, Lucht L, Fei Y, Clark S, Kimak M, He H, Mowery-Rushton P, Barranger J A. Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector. Proc Natl Acad Sci USA. 89:1992;11332-11336.
39. Osiecki-Newman K, Fabbro D, Legler G, Desnick R J, Grabowski G A. Human acid β-glucosidase: use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sites. Biochim Biophys Acta. 915:1987;87-100.
40. Pastores G M, Sibille A R, Grabowski G A. Enzyme augmentation therapy in Gaucher disease type I: Dosage efficacy and adverse effects. Blood. 82:1993;408-416.
41. Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning, a Laboratory Manual. 1989;Cold Spring Harbor Laboratory.
42. Sheriff S, Du H, Grabowski G A. Characterization of lysosomal acid lipase by site-directed mutagenesis and heterologous expression. J Biol Chem. 270:1995;27766-27772.
43. Sorge J, West C, Westwood B, Beutler E. Molecular cloning and nucleotide sequence of the human glucocerebrosidase gene. Proc Natl Acad Sci USA. 82:1985;7289-7293.
44. Sorge J, Kuhl W, West C, Beutler E. Complete correction of the enzymatic defect of type 1 Gaucher disease fibroblasts by retroviral-mediated gene transfer. Proc Natl Acad Sci USA. 84:1987;906-909.
45. Spirin A S, Nemer M. Messenger RNA in early sea-urchin embryos: cytoplasmic particles. Science. 150:1965;214-217.
46. Standart N, Jackson R J. Regulation of translation by specific protein/mRNA interaction. Biochimie. 76:1994;867-879.
47. Summers, M, D, Smith, G, E, A manual of methods for baculovirus vectors and insect cell culture procedures, Texas Agricultural Experimental Station Bulletin, College Station, TX, 1987.
48. Tsuji S, Choudary P V, Martin B M, Stubblefield B K, Mayor J A, Barranger J A, Ginns E I. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease. N Engl J Med. 316:1987;570-575.
49. White B A, Bancroft F C. Cytoplasmic dot hybridization: simple analysis of relative mRNA levels in multiple small cell or tissue samples. J Biol Chem. 257:1982;8569-8572.
50. Xu L, Stahl S K, Dave H P, Schiffmann R, Correll P H, Kessler S, Karlsson S. Correction of the enzyme deficiency in hematopoietic cells of Gaucher patients using a clinically acceptable retroviral supernatant transduction protocol. Exp Hematol. 22:1994;223-230.
51. Xu Y-H, Wenstrup R J, Grabowski G A. Effect of cellular type on expression of acid β-glucosidase: implications for gene therapy in Gaucher disease. Gene Therapy. 2:1995;647-654.
52. Yisraeli J K, Melton D A. Synthesis of long, capped transcripts in vitro by SP6 and T7 RNA polymerases. Meth Enzymol. 180:1989;42-50.